Abrams, Tinya J.
1Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
2 papers on CoChatORCID 0009-0008-1636-1560
Most cited papers
- Verified
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
Liu, C., Lu, H., Wang, H., Loo, A., Zhang, X., Yang, G., Kowal, C., Delach, S., Wang, Y., Goldoni, S., et al. (2021) · Clinical Cancer Research
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 167
- Verified
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
Hao, H.-X., Wang, H., Liu, C., Kovats, S., Velazquez, R., Lu, H., Pant, B., Shirley, M., Meyer, M. J., Pu, M., et al. (2019) · Molecular Cancer Therapeutics
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free